Electrochemotherapy (ECT) uses electroporation to enhance drug delivery into tumor cells, triggering bystander effects like immunogenicity and cell death. This study investigated bystander effects in vitro in 4T1 breast cancer cells following various electroporation treatments: reversible (1400 V/cm, 100 µs) bleomycin electrotransfer, irreversible (2800 V/cm, 100 µs) bleomycin electrotransfer, and calcium electroporation, including combinations. Conditioned media from treated cells (12-72 h incubation) were transferred to untreated cells, and viability was assessed via metabolic activity, cell count, and colony formation. A scratch assay evaluated wound healing. The bystander effect dramatically reduced colony formation, reaching 0% after bleomycin and calcium electrotransfer, and 2.37 ± 0.74% after irreversible electroporation (IRE). Metabolic activity decreased to 18.05 ± 6.77% and 11.62 ± 3.57% after bleomycin and calcium electrotransfer, respectively, and 56.21 ± 0.74% after IRE. Similarly, cell viability measured by flow cytometry was 10.00 ± 1.44%, 3.67 ± 0.32%, and 24.96 ± 1.37% after bleomycin electrotransfer, calcium electrotransfer, and IRE, respectively. Combined analysis of these effects yielded comparable results. Conditioned media, particularly from bleomycin electrotransfer and calcium electroporation, significantly reduced cell number, metabolic activity, and colony formation, demonstrating a strong bystander effect. Wound healing was also significantly delayed in groups exposed to conditioned media.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3390/ijms26052297 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigation of the Bystander Effect on Cell Viability After Application of Combined Electroporation-Based Methods.
Int J Mol Sci
March 2025
Research Institute of Natural Sciences and Technology, Vytautas Magnus University, Universiteto Str. 10, LT-53361 Kaunas, Lithuania.
Electrochemotherapy (ECT) uses electroporation to enhance drug delivery into tumor cells, triggering bystander effects like immunogenicity and cell death. This study investigated bystander effects in vitro in 4T1 breast cancer cells following various electroporation treatments: reversible (1400 V/cm, 100 µs) bleomycin electrotransfer, irreversible (2800 V/cm, 100 µs) bleomycin electrotransfer, and calcium electroporation, including combinations. Conditioned media from treated cells (12-72 h incubation) were transferred to untreated cells, and viability was assessed via metabolic activity, cell count, and colony formation.
View Article and Find Full Text PDFReversible electroporation for cancer therapy.
Br J Radiol
March 2025
Department of Diagnostic and Interventional Radiology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7TF, United Kingdom.
Reversible electroporation (EP) refers to the use of high-voltage electrical pulses on tissues to increase cell membrane permeability. It allows targeted delivery of high concentrations of chemotherapeutic agents including cisplatin and bleomycin, a process known as electrochemotherapy (ECT). It can also be used to deliver toxic concentrations of calcium and gene therapies that stimulate an anti-tumour immune response.
View Article and Find Full Text PDFApplication of Gold Nanoparticles for Improvement of Electroporation-Assisted Drug Delivery and Bleomycin Electrochemotherapy.
Pharmaceutics
September 2024
Department of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, 08406 Vilnius, Lithuania.
Article Synopsis
- Electrochemotherapy (ECT) is a targeted drug delivery method using pulsed electric fields that can struggle with uneven electric field distribution in tumors, leading to reduced treatment effectiveness.
- Researchers explored using 13 nm gold nanoparticles (AuNPs) to enhance electric field strength, aiming to address these non-homogeneity issues in ECT.
- The study found that AuNPs, when combined with specific pulsed electric fields, improved drug permeabilization and electrotransfer, enabling effective electrochemotherapy at lower electric fields without toxicity, showing promise for cancer treatment.
Electrochemotherapy Plus IL-2+IL-12 Gene Electrotransfer in Spontaneous Inoperable Stage III-IV Canine Oral Malignant Melanoma.
Vaccines (Basel)
May 2023
Instituto Universitario de Ciencias de la Salud, Fundación Barceló-CONICET, Buenos Aires 1117, Argentina.
Electrochemotherapy (ECT) is a standard of care in veterinary and human oncology. The treatment induces a well-characterized local immune response which is not able to induce a systemic response. In this retrospective cohort study, we evaluated the addition of gene electrotransfer (GET) of canine IL-2 peritumorally and IL-12 intramuscularly to enhance the immune response.
View Article and Find Full Text PDFThe effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent.
Front Immunol
June 2023
Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Introduction: In calcium electroporation (CaEP), electroporation enables the cellular uptake of supraphysiological concentrations of Ca, causing the induction of cell death. The effectiveness of CaEP has already been evaluated in clinical trials; however, confirmatory preclinical studies are still needed to further elucidate its effectiveness and underlying mechanisms. Here, we tested and compared its efficiency on two different tumor models to electrochemotherapy (ECT) and in combination with gene electrotransfer (GET) of a plasmid encoding interleukin-12 (IL-12).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!